Rexahn Pharma (RNN) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Rexahn Pharma (RNN) Tops Q3 EPS by 1c

Roth Affirms Rexahn Pharma (RNN) at 'Buy'; Broad POC Program Initiation, Archexin Data in mRCC on Tap

November 3, 2015 11:49 AM EST

Roth Capital affirms Rexahn Pharma (NYSE: RNN) with a Buy rating and $3 price target after the company announced Q3 results and offered an update on operations today.

Analyst Joseph Pantginis noted that Rexahn's Q3 loss of $0.02 per share was flat with the firm's... More